Sarcoma Alliance For Research Through Collaboration
Clinical trials sponsored by Sarcoma Alliance For Research Through Collaboration, explained in plain language.
-
Promising drug targets rare cancer that blocks blood vessels
Disease control Recruiting nowThis study tests a drug called nab-sirolimus in 41 people with a rare cancer of the blood vessels (EHE) that is growing or causing symptoms. The drug is given through a vein twice every 3 weeks. The main goal is to see if it shrinks tumors. This is a phase 2 trial, meaning it's c…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New drug offers hope for rare sarcoma patients
Disease control Recruiting nowThis study tests a drug called tebentafusp in people with a rare type of cancer called clear cell sarcoma that has spread or cannot be removed by surgery. Only people with a specific genetic marker (HLA-A*02:01) can join. The main goal is to see if the drug can stop the cancer fr…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 22, 2026 13:53 UTC